Investigating claim Trump got exclusive access to potent obesity drug retatrutide
The claim that Trump had exclusive access to the obesity drug retatrutide lacks sufficient evidence from reliable sources.
We review public claims using verifiable sources and transparent reasoning. Our goal is to help you quickly understand what is known, what is unclear, and what evidence exists.
The claim that Trump had exclusive access to the obesity drug retatrutide lacks sufficient evidence from reliable sources.
The claim about JPMorgan Chase firing an DEI executive for stealing a Knicks trash can is unverified.
The claim cannot be verified or refuted with the provided sources.
The claim that Florida ranks 49th in avoidable hospital costs cannot be verified with the given sources.
The claim that misleading posts compare the ID requirements for entering the Obama Presidential Center to voter ID laws is unverified.
The claim that Grimsby housing development homes are not 'exclusively for immigrants' cannot be verified with the given sources.
The claim cannot be verified with the provided sources.
The claim that more AI-generated videos of small boat crossings circulate on Facebook cannot be verified with the given sources.
The claim about fact-checkers reporting challenges and resilience at GlobalFact 2026 cannot be verified with the provided sources.
The claim lacks sufficient evidence to determine if Obama's administration failed to compensate black contractors adequately for their work on the library proje…
The claim that Tulsi Gabbard reportedly took political orders from her ‘guru’ is unverified.
The claim about Betsy Ross, Paul Revere, and George Washington's teeth is based on historical myths that lack sufficient evidence.